Translate this page into:
Magnetic resonance permeability for the evaluation of head and neck tumors: Parotid and beyond
-
Received: ,
Accepted: ,
How to cite this article: Nagano SYM, Chojniak R, Porto GC. Magnetic resonance permeability for the evaluation of head and neck tumors: Parotid and beyond. J Clin Imaging Sci. 2025;15:12. doi: 10.25259/JCIS_173_2024
Abstract
Head and neck cancer is the seventh most common cancer globally, with over 300 thousand deaths annually. Magnetic resonance imaging (MRI) of head and neck tumors is a well-known method for its evaluation, although malignant and benign imaging tumors often overlap. Permeability is an advanced method performed by MRI that assist in the diagnosis and evaluation of the neoplasm treatments, having a well-established role in some cases, such as salivary gland tumors, and promising in others, such as squamous cell carcinoma and lymph node evaluation. This pictorial review aims to demonstrate the diverse applications of magnetic resonance permeability imaging in head and neck tumors, highlighting its role in differentiating benign from malignant lesions, such as parotid gland tumors, assessing head and neck squamous cell carcinoma, and evaluating lymph node involvement. By correlating these advanced imaging findings with conventional magnetic resonance techniques, this review aims to enhance radiologists’ understanding of the method and its clinical utility in improving diagnostic and treatment planning.
Keywords
Carcinomas
magnetic resonance imaging
oncology
permeability
head and neck
INTRODUCTION
Head and neck cancer is the seventh most common cancer globally, accounting for over 325,000 deaths annually. The incidence rates are rising, driven by the factors such as human papillomavirus infection and betel nut use.[1] Magnetic resonance imaging (MRI) is a well-known method of imaging used for the evaluation of head and neck tumors being well-known the conventional sequences T1, T2, diffusion, and Gadolinium T1 postcontrast. Although this assessment is widely recognized, there is considerable signal overlap between different head and neck tumors when only conventional techniques are used, making it impossible to distinguish between tumoral types, especially malignant and benign tumors when only the basic signal characteristics are studied.[2] Dynamic contrast enhanced (DCE), on the other hand, is an advanced technique in MRI used to evaluate microcirculation at the capillary level, when contrast passes from the vessels into the interstitial space. This process alters the relaxation time of water molecules and varies depending on the type of tissue involved.[2] Today DCE, also known as permeability, has a well-known role in the evaluation of parotid tumors, mainly because it can effectively differentiate Warthin’s tumor from other types, reducing the need for invasive procedures for this diagnosis.[3] It is also being studied in other areas, such as the evaluation of head and neck squamous cell carcinomas (HNSCC) diagnosis, recurrence and lymph node assessment.[4]
Since permeability is an advanced and relatively unknown technique, most radiologists can only interpret its use in parotid tumors; however, its applications are much broader. The aim of this study is to educate radiologists and other physicians about the additional applications of permeability in the study of the head and neck, such as in the evaluation of the most common head and neck tumor, squamous cell carcinoma, both for staging and posttreatment assessment.
MATERIAL AND METHODS
This retrospective and educational study used anonymized imaging data from a digital archive. As the study involved only anonymized retrospective data, submission to the ethics committee was not required. Data were analyzed to explore permeability’s broader applications in tumor evaluation.
DISCUSSION
Permeability is an advanced technique in MRI used for the evaluation of the microcirculation at the capillary level in a dynamic assessment especially on how the contrast agents pass from the vessel to the extravascular compartment (tissue) and vice versa. These patterns can be measured and correlated to the conventional MRI for the better evaluation of tumors. The principle is based on the fact that malignant tissues have disorganized vessels and promote greater and faster contrast extravasation from the vessel to the tissue and a slower outflow. Some softwares can quantify the rate at which contrast agent moves from the blood plasma into the extravascular extracellular space (Ktrans) and the rate of contrast agent returning to the plasma (Kep)[4] [Figure 1a]. Even when the machine does not have the software available, permeability sequences can be evaluated using qualitative methods. Among these is the graph known as the permeability curve, where the x-axis represents the time since gadolinium injection and the y-axis indicates the signal intensity of the contrast. The curve formed over time displays wash-in and washout values that vary between benign and malignant tumors, with benign tumors generally showing a curve with slow wash-in and progressive washout, while malignant tumors exhibit a curve with rapid wash-in and slower washout, creating a descending pattern[4] [Figure 1b]. In addition to the curves, the machine also generates a parametric color map where areas with higher Ktrans values are represented by warm colors, such as red and orange, and areas with lower values are displayed with cool colors, like blue[4] [Figure 1c].

The initial studies of MRI DCE were conducted to evaluate parotid tumors, and today, it is a validated complementary method that can even exclude the need for fine-needle biopsy in certain cases, such as when conventional imaging and permeability findings are consistent with a Warthin tumor.[4] Tumors have distinct signal characteristics in conventional and permeability imaging, which can assist in the diagnosis. Pleomorphic adenoma typically shows high signal on T2 [Figure 2a], no diffusion restriction, high-permeability voxels represented by warm colors [Figure 2b], and an ascending permeability curve[3] [Figure 2c]. Warthin tumor’s usually exhibit isointense or low T2 signal [Figure 3a], high-permeability voxels represented by warm colors [Figure 3b] and permeability with a washout >30% [Figure 3c and d], while malignant tumors, such as adenoid cystic carcinoma, tend to present with variable T2 signal [Figure 4a], diffusion restriction [Figure 4b], color map [Figure 4c], a rapid ascending curve, and a descending plateau washout [Figure 4d].[3]


Other applications are being studied for head and neck tumors, many of them focusing on the assessment of HNSCC. Some studies focus on the staging process, aimed at the evaluation of tumor extent. For example, for laryngeal neoplasms, edema or reactive thickening of the laryngeal cartilage may occur [Figure 5a and b], and permeability studies can be useful in differentiating between stages T3 and T4, especially concerning possible lateral margin extension with thyroid cartilage involvement[5] [Figure 5c]. In addition to the evaluation of tumor extent, some quantitative methods of permeability used in staging assessment can also provide information on the stages of squamous cell carcinoma. This has been described in oral cavity tumors, particularly in tongue neoplasms, where the constant Kep, which, as previously mentioned, represents the rate of contrast returning to the plasma, has been characterized as an independent predictor of higher stages of squamous cell carcinoma (stages III and IV). Usually, in advanced stages, Kep is reduced because of tumor hypoxia and reduction in functional microvascularization [Figure 6] - adapted from Guo et al. (2020).[6] In the staging evaluation process, the qualitative and quantitative characteristics of the permeability graph in HNSCC follows the same pattern as malignant parotid tumors, with a high Ktrans, and a rapid wash-in and slow washout. Remember that, in addition to the graph, the parametric map also provides information on areas with higher permeability (indicated by warmer colors) and can assist in the evaluation of head and neck squamous cancer,[4] for example, in the oral tongue [Figure 7] and oropharynx [Figure 8]. An additional aspect of permeability is in the evaluation of HNSCC after treatment. As previously exemplified, malignant tumors typically have a poorly organized capillary network, and permeability studies help in the early detection of recurrence, assessing tumor extent, and facilitating staging. Posttreatment changes (radiotherapy and chemotherapy) include fibrosis, edema, and soft-tissue thickening, sometimes even necrosis, and distinguishing between posttreatment changes and tumor recurrence can be challenging. Studies have shown that when permeability is included in the evaluation of posttreatment squamous cell carcinoma, it can cause a reduction in false positive and negative rates compared to when evaluating MRI alone and also improve specificity[7] [Figures 9 and 10]. Quantitative permeability parameters in HNSCC assessment have also been correlated with immunohistochemical tumor findings. Especially Ktrans has the potential to indicate angiogenesis and proliferative activity which are often linked to higher grade tumors and worse prognosis.[8]







Another application is in identifying and differentiating between benign and malignant lymph nodes, as the former usually exhibit a higher permeability.[9] In the context of lymph nodes, studies have also been conducted to determine whether the presence of metastatic lymph nodes can predict patients’ prognosis posttreatment. There is evidence suggesting that their response to chemotherapy and radiotherapy depends on the amount of oxygen present in the tumor. Thus, lymph nodes with reduced permeability are likely to have a worse prognosis[9] [Figure 11].

Permeability imaging has been explored in head and neck tumors beyond its established roles previously depicted. Notably, it aids in differentiating neural sheath tumors and paragangliomas, with schwannomas typically exhibiting slower wash-in and wash-out curves reflecting their more structured microvascular architecture [Figure 12]. In contrast, paragangliomas due to their high vascularity show rapid wash-in and washout [Figure 13] and also higher Ktrans and Kep.[10] In addition, permeability imaging has shown promise in the differentiation of benign and malignant thyroid and orbital tumors, further expanding its clinical applications.[10] These differences highlight the potential of DCE-MRI in improving diagnostic accuracy and reducing the need for invasive procedures.


All of this demonstrates the versatility and importance of DCE in the daily study of head and neck tumors.
CONCLUSION
Permeability imaging through DCE-MRI has become a great tool in the evaluation of head and neck tumors, offering enhanced diagnostic accuracy, staging, and treatment monitoring. Its ability to quantify vascular dynamics and differentiate between benign and malignant lesions complements conventional MRI, reducing false positives and negatives, and improving sensitivity and specificity. Beyond parotid tumor characterization, its applications extend to staging and recurrence of HNSCC, lymph node analysis, and ongoing studies exploring tumor biomarkers and other tumor types.
Ethical approval
The Institutional Review Board approval is not required.
Declaration of patient consent
Patient’s consent not required as there are no patients in this study.
Conflicts of interest
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation
The authors confirms that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Reviewing the epidemiology of head and neck cancer: Definitions, trends and risk factors. Br Dent J. 2022;233:780-786.
- [CrossRef] [PubMed] [Google Scholar]
- Perfusion and permeability imaging for head and neck cancer: Theory, acquisition, postprocessing, and relevance to clinical imaging. Magn Reson Imaging Clin N Am. 2018;26:19-35.
- [CrossRef] [PubMed] [Google Scholar]
- Interpretation pearls for MR imaging of parotid gland tumor. Eur Ann Otorhinolaryngol Head Neck Dis. 2013;130:30-5.
- [CrossRef] [PubMed] [Google Scholar]
- Dynamic contrast-enhanced MR imaging in head and neck cancer: Techniques and clinical applications. AJNR Am J Neuroradiol. 2016;37:588-95.
- [CrossRef] [PubMed] [Google Scholar]
- Functional magnetic resonance imaging of head and neck cancer: Performance and potential. Neuroradiol J. 2019;32:36-52.
- [CrossRef] [PubMed] [Google Scholar]
- Quantitative dynamic contrast-enhanced MR imaging can be used to predict the pathologic stages of oral tongue squamous cell carcinoma. BMC Med Imaging. 2020;20:117.
- [CrossRef] [PubMed] [Google Scholar]
- Detection of local recurrence in patients with head and neck squamous cell carcinoma using voxel-based color maps of initial and final area under the curve values derived from DCE-MRI. AJNR Am J Neuroradiol. 2019;40:1392-401.
- [CrossRef] [PubMed] [Google Scholar]
- The correlations between dynamic contrast enhanced magnetic resonance imaging and immunohistochemical data in head and neck squamous cell carcinomas. Turk J Med Sci. 2022;52:26.
- [CrossRef] [PubMed] [Google Scholar]
- Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head and neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys. 2012;82:1837-44.
- [CrossRef] [PubMed] [Google Scholar]
- Dynamic contrast-enhanced magnetic resonance imaging for differentiating head and neck paraganglioma and schwannoma. Head Neck. 2021;43:2611-22.
- [CrossRef] [PubMed] [Google Scholar]


